Furthermore, the enriched KEGG pathways of the TCPTC-related downregulated DEGs included pathways in cancer, neuroactive ligand-receptor interactions, PI3K-Akt signaling, MAPK signaling, and cAMP signaling (Fig. 5D). The gene discussed is AKT1; the disease is cancer.